Clinical excellence for better outcomes

We’re leading with high sensitivity, optimal precision, and world-class Sigma values, including some of the industry’s only CDC-certified assays.

Accurate test results

Accurate test results…

Accurate results enable you to assess results with a high level of confidence.

doctor and lab tech

…at the right time…

Faster test results help provide you with the critical information needed for patient care.

immunoassy and chemistry assay menu

…from an expansive menu

Our immunoassy and chemistry assay menu comprises over 200 tests and counting.1

Our industry-leading assays

We’re leading the industry with our assays, including true high-sensitivity troponin, B•R•A•H•M•S Procalcitonin, key infectious diseases, drugs of abuse, and Enhanced Liver Fibrosis.

person with hand on chest

High-sensitivity Troponin I

Provides precise results across over 90% of the low end of detection. Enables a clearer clinical assessment with sex specific cutoffs, meeting the guidelines for a true high sensitivity troponin assay for both men and women. Shows high tolerance to common interferents.3

B•R•A•H•M•S Procalcitonin

B•R•A•H•M•S Procalcitonin

Proven B.R.A.H.M.S PCT technology brings advantages of lowend sensitivity, optimal precision at the decision points, workflow excellence, and no biotin interference for better patient care.4

Infectious diseases

Infectious diseases

ID assays include SARS-Cov-2 Serology5, Hepatitis B, Syphilis, and a 4th-generation CHIV assay. They provide high sensitivity and improved specificity for the highest level of confidence and early detection.

Drugs of abuse

Drugs of abuse

Eight-assay drugs-of-abuse menu combines proven technology and workflow excellence on one automated platform. Includes Fentanyl II, Tramadol, Buprenorphine, Oxycodone, and more.

Enhanced Liver Fibrosis (ELF)

Enhanced Liver Fibrosis (ELF)

The ELF™ Test is a noninvasive blood test that measures three direct markers of fibrosis. In conjunction with other laboratory and clinical findings, the ELF test can be used in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.6

By clicking Submit you consent to the processing of your above given personal data by the Siemens Healthineers company referred to under Corporate Information and for the purpose described above. Further information concerning the processing of your data can be found in the Data Privacy Policy. You are aware that you can partially or completely revoke this consent at any time for the future. Please declare your revocation to the contact address given in the Corporate Information and sent it to us via the following e-mail address: dataprivacy.func@siemens-healthineers.com.

1

2

3

4

5

6